CHBIO Business Summary

CH Biotech R&D Co., Ltd. (CHBIO) operates a specialized "Taiwan R&D, US Manufacturing, Global Marketing" business model, generating revenue through the development and sale of high-margin agricultural biotechnology products. Its primary business segments are Plant Growth Regulators (PGR), which account for approximately 77% of revenue, and specialty micronutrient fertilizers, contributing 22%. By maintaining its production facilities in California, CHBIO leverages "Made in USA" branding to serve its dominant North American market, which constitutes over 90% of its total sales. The company occupies a premium niche in the precision agriculture sector, focusing on climate-resilient and carbon-reducing crop solutions. It competes globally and regionally against major players such as Corteva Agriscience, Nufarm, Sinon Corp (1712.TW), and Taiwan Fertilizer (1722.TW). The company was founded in 2013 by Chairman Wu Chen-pang (Cheng-Pang Wu) and Denny Ng, with Wu’s extensive background in the U.S. agricultural market serving as the firm's strategic foundation. As of March 31, 2026, the leadership team is led by Wu Chen-pang as Chairman and General Manager, supported by Chief Financial Officer Zhang Yin-teng (appointed March 2026) and Spokesperson Luo Xin-jun. Technical leadership is provided by CTOs Kuei Chun Li and Jung Yu Chen. CHBIO’s institutional pedigree is highlighted by its strategic partnership with Nutrien Ltd., the world’s largest fertilizer company, which holds a 22.5% stake through its subsidiary Loveland Products Canada Inc. Other notable board-level investors include Wealth Milestone Investment Corp., providing the company with a robust global distribution network and significant capital stability.